 - PHASE I: Histological confirmation of relapsed recurrent after previous therapyies or refractory no response to previous therapyies B-cell NHL; note: patients with small lymphocytic lymphoma SLL are eligible however patients with chronic lymphocytic leukemia CLL are not eligible 